Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ADMA Biologics Inc (NASDAQ:ADMA)

3.25
Delayed Data
As of Sep 21
 -0.04 / -1.22%
Today’s Change
2.67
Today|||52-Week Range
7.70
-36.52%
Year-to-Date
No recent news for ADMA Biologics Inc.

Today’s Trading

Previous close3.29
Today’s open3.30
Day’s range3.19 - 3.32
Volume2,380
Average volume (3 months)54,568
Market cap$84.9M
Dividend yield--
Data as of 3:57pm ET, 09/21/2017

Growth & Valuation

Earnings growth (last year)+6.94%
Earnings growth (this year)-20.50%
Earnings growth (next 5 years)--
Revenue growth (last year)+48.53%
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CYTRCytRx Corp+0.00+0.58%
PFNXPfenex Inc-0.04-1.27%
SRRASierra Oncology Inc+0.03+1.92%
CFRXContraFect Corp+0.04+4.02%
Data as of 7:59pm ET, 09/21/2017

Financials

Next reporting dateNovember 14, 2017
EPS forecast (this quarter)-$0.43
Annual revenue (last year)$10.7M
Annual profit (last year)-$19.5M
Net profit margin-183.05%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Adam S. Grossman
Chief Financial &
Principal Accounting Officer, VP
Brian Lenz
Corporate headquarters
Ramsey, New Jersey

Forecasts